Novartis - Analysis of sickle cell disease data in the Australian Haemoglobinopathy Registry

Project: Research

Project Details

StatusFinished
Effective start/end date1/12/191/03/21

Funding

  • Novartis Pharmaceuticals (New South Wales): AUD276,231.00